Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin on Nighttime Blood Pressure in Type 2 Diabetes
NCT03887416Phase 4Unknown
- Sponsor
- LM Diagnósticos
- Start
- Apr 2019
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dapagliflozin in type 2 diabetes mellitus (T2DM), sponsored by LM Diagnósticos. Status: unknown.
02
Drugs
dapagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03887416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03887416.